Thema
Journal Article
65
Influenza Vaccines
42
Research Support, Non-U.S. Gov't
36
Antibodies, Viral
28
Vaccines, Attenuated
28
live attenuated influenza vaccine
15
Influenza
11
Live attenuated influenza vaccine
11
Review
11
SARS-CoV-2
11
influenza
9
615
8
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
8
Antibodies, Neutralizing
8
che
8
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
7
Hemagglutinin Glycoproteins, Influenza Virus
7
Vaccines, Inactivated
7
bio
7
universal influenza vaccine
7
COVID-19
6
Randomized Controlled Trial
6
cross-protection
6
Clinical Trial, Phase I
5
Cross-protection
5
Editorial
5
Pandemics
5
Vaccines, Synthetic
5
immunogenicity
5
safety
5
COVID-19 Vaccines
4
Epitopes
4
Epitopes, T-Lymphocyte
4
Immunoglobulin A
4
Immunoglobulin G
4
Universal influenza vaccine
4
Vaccines
4
Viruses
4
clinical trial
4
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
3
Comment
3
Conserved protein
3
EC 3.2.1.18
3
Hemagglutinins
3
IgG
3
Immunogenicity
3
Influenza M2 ectodomain
3
Influenza a virus
3
LAIV
3
M2e antigen
3
mehr ...